triumph 1 retatrutide A summary slide of the TRIUMPH-1 data presented today by Dr. Ania Jastreboff at #ADA2026 🚨 TRIUMPH-1: Phase 3 Obesity Trial with Retatrutide 🚨 Retatrutide 💉, a once-weekly triple hormone receptor Retatrutide produces up to 30.3%

We can help you clean it up, simplify it, and identify overlap

But raw percentages can be misleading without understanding the trial designs, patient populations, and timelines involved

Unlike traditional treatments, GLP-1 drugs delay gastric emptying and reduce appetite, contributing to better glycemic control and weight loss

GLP-1 drugs can significantly support weight loss and treat symptoms of type 2 diabetes by mimicking a hormone your body naturally uses to regulate your blood sugar and appetite

it is provided with the understanding that Poosh, LLC (Poosh) is not engaged in the provision or rendering of medical advice or services